Financial Ratios

AHLCON PARENTERALS (INDIA) LTD.

NSE : NABSE : 524448ISIN CODE : INE027C01011Industry : Pharmaceuticals & DrugsHouse : Ahlcon Parenterals - MNC
BSE515.000 (0 %)
PREV CLOSE ( ) 515.00
OPEN PRICE ( ) 515.00
BID PRICE (QTY) 515.00 (2000)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29501
TODAY'S LOW / HIGH ( )514.75 516.75
52 WK LOW / HIGH ( ) 514.75517.25
NSE
This Company is not listed in NSE
Select year
ParticularsMar2022Mar2021Mar2020Mar2019Mar2018
Operational & Financial Ratios
   Earnings Per Share (Rs)-27.48-65.31-21.65-66.07-60.30
   CEPS(Rs)7.90-28.238.37-20.69-6.15
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-161.00-133.52-68.21-46.5619.51
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)15.203.3418.407.6212.44
   EBIT Margin(%)3.33-15.776.85-12.20-10.31
   Pre Tax Margin(%)-11.26-35.54-8.93-30.56-28.25
   PAT Margin (%)-11.26-35.54-8.93-30.56-28.25
   Cash Profit Margin (%)3.24-15.363.46-9.57-2.88
Performance Ratios
   ROA(%)-7.33-16.82-5.07-14.59-12.50
   ROE(%)0.000.000.000.00-121.43
   ROCE(%)2.65-8.894.65-6.72-5.00
   Asset Turnover(x)0.650.470.570.480.44
   Sales/Fixed Asset(x)0.430.330.440.400.42
   Working Capital/Sales(x)-2.83-0.59-1.33-0.78-0.92
Efficiency Ratios
   Fixed Capital/Sales(x)2.313.032.262.482.39
   Receivable days40.7153.8754.9762.9469.44
   Inventory Days47.0261.9354.9052.1541.08
   Payable days58.6799.0496.23107.0066.38
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)1.892.421.771.941.97
   EV/Core EBITDA(x)10.5854.939.1822.0812.77
   EV/EBIT(x)56.73-15.3525.78-15.93-18.65
   EV/CE(x)1.201.211.050.940.89
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)32.77-24.1612.094.0110.54
   Core EBITDA Growth(%)436.96-82.63145.13-40.8317.04
   EBIT Growth(%)127.99-274.62162.96-19.77-556.55
   PAT Growth(%)57.93-201.7267.24-9.56-214.11
   EPS Growth(%)57.93-201.7267.24-9.56-214.11
Financial Stability Ratios
   Total Debt/Equity(x)-2.93-3.26-6.13-8.8220.57
   Current Ratio(x)0.530.140.290.240.23
   Quick Ratio(x)0.330.070.150.130.15
   Interest Cover(x)0.23-0.800.43-0.66-0.57
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.